Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center
- Conditions
- LaparoscopyBladder Cancer
- Interventions
- Procedure: Open radical cystectomyProcedure: Laparoscopic-assisted radical cystectomy
- Registration Number
- NCT04838873
- Lead Sponsor
- Cairo University
- Brief Summary
This study is a prospective randomised controlled study of urinary bladder cancer patients presented to urology unit at National Cancer Institute; Cairo University.
- Detailed Description
The study will randomise 60 patients to one of two arms; laparoscopic-assisted radical cystectomy and open radical cystectomy. The focus of the study will be a comparison of both approaches on the patients' peri-operative outcome.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Patients with transitional cell carcinoma, squamous cell carcinoma and urinary bladder adenocarcinoma.
- Patients fit for surgery (ECOG Performance Status 0,1).
- Patients with medical comorbidities that preclude surgical management or minimally invasive techniques.
- Patients with advanced hydronephrosis or renal failure.
- Patients refusing surgery.
- Patients with urinary bladder cancer invading bladder neck or prostatic urethra.
- Patients with metastatic urinary bladder cancer.
- Patients who received prior pelvic radiotherapy.
- Patients refusing randomization and/or participation in the trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Open Radical Cystectomy Open radical cystectomy Standard open radical cystectomy. Laparoscopic-assisted radical cystectomy. Laparoscopic-assisted radical cystectomy Laparoscopic-assisted radical cystectomy.
- Primary Outcome Measures
Name Time Method Operative time During surgery OR time as measured in minutes, divided into time required to perform the cystectomy, lymph node dissection, and urinary diversion.
Visceral injury During surgery Any organ injury encountered during the operation.
Urine leak Up to 4 weeks Leakage of urine from urinary enteric anastomosis
Wound dehiscence, infection. Up to 4 weeks Wound gaping, evisceration or infection.
Venous thromboembolism Up to 2 months DVT or pulmonary embolism
Blood loss During surgery EBL as measured in millilitres, including the effluent from the suction canister as well as estimates of the gauze swabs.
Time to oral intake Immediate post-operative period Measured in days
Conversion rate During surgery Rate of conversion from laparoscopy to open surgery
Re-admission rate. Intra-operative to sixth months. Re-hospitalization requirement.
Opioid requirements. During surgery through first post-operative week. Requirement, dose and duration of narcotic analgesia.
Sepsis Up to 4 weeks Infection triggering a systematic immune response
Length of hospital stay Immediate post-operative period. LOS as measured in days
Enteric fistula Up to 4 weeks Leakage of intestinal contents due to failure of entero-enteric anastomosis
- Secondary Outcome Measures
Name Time Method Lymph node retrieval Within 10 days post surgery. Number of lymph nodes retrieved by open versus laparoscopic approaches.
pN stage Within 10 days post surgery. Lymph node metastasis (positive or negative), and number of positive nodes if present.
pT stage Within 10 days post surgery. Pathologic tumor stage (Stage 1, stage 2, stage 3 or stage 4)
Surgical margins Within 10 days post surgery Positive margins or negative margins. Location of positive margins (Urethral, ureteric)
Histological grade Within 10 days post surgery Low grade, intermediate grade or high grade
Trial Locations
- Locations (1)
National Cancer Institute
🇪🇬Cairo, Egypt